Ramelteon Tablet — FDA Drug Shortage

To Be Discontinued — Takeda Pharmaceuticals USA Inc.

The FDA lists a drug shortage record for Ramelteon Tablet (tablet) from Takeda Pharmaceuticals USA Inc. with status To Be Discontinued. The shortage was first posted on Mar 19, 2026.

Shortage details

Status
To Be Discontinued
Company
Takeda Pharmaceuticals USA Inc.
Package NDC
64764-805-10
Dosage Form
Tablet
Presentation
Rozerem, Tablet, 8 mg (NDC 64764-805-10)
Initial Posting
Mar 19, 2026

Sources: openFDA, FDA Data Dashboard, FDA.gov. Report a data issue: hello@regdatalab.com.